Boston Scientific touts win in continued TAVR patent spat with Edwards Lifesciences  Mass Device

Boston Scientific (NYSE:BSX) today claimed a win in an ongoing patent spat with Edwards Lifesciences (NYSE:EW) over transcatheter aortic valve replacement …